AGP Limited (PSX:AGP)

Pakistan flag Pakistan · Delayed Price · Currency is PKR
179.95
-0.06 (-0.03%)
At close: Mar 27, 2026
Market Cap50.39B -5.2%
Revenue (ttm)28.89B +15.4%
Net Income3.74B +39.9%
EPS13.34 +39.9%
Shares Out280.00M
PE Ratio13.49
Forward PE10.78
Dividend8.00 (4.45%)
Ex-Dividend DateApr 10, 2026
Volume2,032,016
Average Volume588,088
Open182.00
Previous Close180.01
Day's Range175.00 - 187.00
52-Week Range142.00 - 258.67
Beta0.23
RSI38.94
Earnings DateMar 2, 2026

About AGP Limited

AGP Limited manufactures, sells, wholesales, distributes, exports, imports, markets, deals in pharmaceutical and healthcare products in Pakistan and Afghanistan. The company offers products in the areas of aminoglycosides, angiotensin II antagonist, anti-epileptics, anti-gout, anti-infective antidiarrheal, anti-inflammatory enzyme, antidiarrheal microorganisms, antifibrinolytic, antihistamines systemic, antileuk anti-ashtm sys, antineoplastic agent, anti-obesity, antirheumatic non-steroid, antispasmodic and anticholinergic plain, atypical antip... [Read more]

Industry Pharmaceuticals
Sector Healthcare
Founded 1989
Employees 2,143
Stock Exchange Pakistan Stock Exchange
Ticker Symbol AGP
Full Company Profile

Financial Performance

In 2025, AGP Limited's revenue was 28.89 billion, an increase of 15.40% compared to the previous year's 25.03 billion. Earnings were 3.74 billion, an increase of 39.91%.

Financial Statements